Published By
Created On
18 Aug 2021 20:35:23 UTC
Transaction ID
Cost
Safe for Work
Free
Yes
More from the publisher
press-secretary-kayleigh-mcenany-holds-7
https://george.news | Use Subtitles for Official Transcript | Press Secretary Kayleigh McEnany Holds a Briefing ~ White House Communications Agency
Office of the Press Secretary, FOR IMMEDIATE RELEASE, June 19, 2020
PRESS BRIEFING, BY PRESS SECRETARY KAYLEIGH MCENANY, James S. Brady Press Briefing Room
1:34 P.M. EDT | MS. MCENANY: Good afternoon everyone. The great American comeback is underway. Just before joining you all, we learned from the Bureau of Labor Statistics that unemployment has fallen in 43 states in May, as Americans are going back to work.
Also, I would like to reemphasize the numbers that Director of the NEC Larry Kudlow shared with you all yesterday that the CBO predicted that, in the third quarter, we will get plus-20 percent GDP. They’ve predicted in Q4, we will be at plus-20 percent GDP. And top economist Ed Hyman says that, in Q1 of 2021, he is predicting plus-5 in GDP. And this would put GDP above its 2019 peak. That’s right. So pre-coronavirus numbers, should those predictions pan out. We are back and we will be booming.
Finally -- well, second to finally, we are encouraged that we continue to gather positive data on a number of therapeutics. Heparin, dexamethasone -- or steroids, is as it's more commonly known; convalescent plasma; and remdesivir have all shown promise in treating coronavirus. Preliminary findings in a large, UK-based recovery trial found that when steroids were used, there was a 30 percent reduction in death for coronavirus patients on ventilators. The FDA is reviewing this recovery trial data now.
Additionally, on convalescent plasma, there is more encouraging news. In partnership with Mayo Clinic, the Trump administration moved very quickly on this therapy in its earliest days, recognizing that it showed promise. Though the -- through the FDA, Mayo Clinic, and the administration's work and our hand-in-hand partnership, we've found that this treatment is very promising. This has shown that the administration has left no stone unturned in looking at every possible treatment at the very earliest stages.
The lead investigator of this Mayo Clinic study, Dr. Michael Joyner, summed up his work, in saying that convalescent plasma, quote, “continues to look promising,” end quote, noting the, quote, “excellent news” of this study, which covered a diverse population of patients. About 20 percent were African American, nearly 35 percent Hispanic, 5 percent Asian, and 40 percent women.
Prior experience with respiratory viruses in some data that have emerged globally suggest that convalescent plasma has the potential to lessen the severity or shorten the length of the illness caused by COVID-19. The results from Mayo underscore that promise.
As you can see, the Trump administration
...
https://www.youtube.com/watch?v=0DGp2qFlFQ4
Transaction
Created
4 weeks ago
Content Type
Language
video/mp4
English